BCL2 and diabetes mellitus: Simultaneously, chronic HPTQ treatment debilitated diabetes-induced cognitive deficits and regulated hippocampal insulin metabolism activated CREB/BDNF/TrkB signaling pathway and suppressed the mitochondria-related Bax/Bcl-2 and caspase-3 apoptosis pathway.